|
|
5980 Horton St., Suite 525 Emeryville, CA 94608 USA phone:510-547-3610 fax:510-547-3604
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.neosil.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Dermatology-focused specialty pharmaceuticals with a focus on hair loss. |
 |
| Management |
| Eugene Bauer, M.D., CEO; Clarence Dellio, President and COO |
| |
|
|
| |
|
| Keywords |
| dermatology, hair growth, peptide, preclinical |
|
|
|
| Description |
|
Neosil is a privately-held dermatology-focused specialty pharmaceutical company with several products in pre-clinical development. |
 |
| Products / Services |
Neosil's lead product is a prescriptive hair growth peptide that demonstrates significant capacity to promote hair growth in a preclinical model. This product has been employed in a small Phase I/II clinical trial in which it showed significant promotion of hair growth in more than one-half of the patients with androgenetic alopecia.
|
 |
 |
|
|
|
|
|
|